Charting the Changing Landscape in Treatment Options for Diabetic Macular Edema

Sunir J. Garg, MD

September 18, 2023

Sunir J. Garg, MD, discusses the evolution of treatment options for patients with diabetic macular edema (DME) that he has witnessed throughout his career. The first patients with DME were treated with focal and pan-retinal lasers, which slowed down vision loss and prevented blindness.

However, when intravitreal injections were introduced, first with steroids and then with anti–vascular endothelial growth factor medicines, this resulted in improved vision for patients that lasted for months or even years. Compared with lasers, patients should know that intravitreal injections are a greater commitment that require up to two dozen treatments.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Charting the Changing Landscape in Treatment Options for Diabetic Macular Edema - Medscape - Sep 18, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Charting the Changing Landscape in Treatment Options for Diabetic Macular Edema

Tables

Authors and Disclosures

Authors and Disclosures

Expert

Sunir J. Garg, MD

Comments

Email This

Feedback